Prophylaxis Pharmacological Management for Patients with Intraoperative Floppy Iris Syndrome Risk Due to ?1-Adrenergic Receptor Antagonists Use
DOI:
https://doi.org/10.35749/journal.v48i2.100514Keywords:
alpha-1 adrenergic receptor antagonists, pharmacological prophylaxis, intraoperative floppy iris syndromeAbstract
Introduction: Intraoperative floppy iris syndrome (IFIS) remains a challenge that increases the risk of complications in patients undergoing cataract surgery who use ?1-adrenergic receptor antagonists. To date, no definite consensus on a preventive strategy for IFIS is available. The aim of this review is to assess various pharmacological managements to prevent IFIS in high-risk patients.
Methods: This review was based on Preferred Reporting Items for Systematic Reviews and Meta- Analyses guidelines. A systematic search using PubMed, Science Direct, Cochrane Library, and WorldCat database was performed. Quality of each study was evaluated using Cochrane Risk of Bias 2.0 (RoB 2.0), Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I), or Newcastle- Ottawa Scale (NOS).
Results: The search identified 1589 articles of which 7 met the eligibility criteria. Experimental and observational studies between 2010 and 2018 were included. Pharmacological managements included in this review are administered in varying routes. Phenylephrine, lidocaine, a combination of lidocaine and epinephrine are given intracamerally. Other pharmacological managements included are sub-tenon injection of lidocaine, topical atropine, a combination of topical atropine with intracameral epinephrine, combined irrigation solution of phenylephrine and ketorolac, and mydriatic cocktail- soaked wick sponges.
Conclusion: Various pharmacological managements for IFIS prophylaxis have shown promising potential. However, studies that evaluate the efficacy of each agent and comparison between these strategies are still limited. Further research is needed to determine the best prophylaxis strategy to reduce the incidence of IFIS.
Downloads
References
Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. Journal of Cataract and Refractive Surgery. 2005;31(4):664–73.
Yang X, Liu Z, Fan Z, Grzybowski A, Wang N. A narrative review of intraoperative floppy iris syndrome: an update 2020. Annals of Translational Medicine. 2020 Nov;8(22):1546–1546.
Christou CD, Tsinopoulos I, Ziakas N, Tzamalis A. Intraoperative floppy iris syndrome: Updated perspectives. Clinical Ophthalmology. 2020;14:463–71.
Lunacek A, et al. Ten years of intraoperative floppy iris syndrome in the era of ?-blockers. Central European journal of urology. 2018;71(1):98–104.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Vol. 372, The BMJ. BMJ Publishing Group; 2021.
Sterne JAC, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. The BMJ. 2019;366:1–8.
Sterne JA, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Online). 2016;355:4–10.
McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Research Synthesis Methods. 2020 Apr 26;12:55–61.
Wells GA, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute. 2013.
Chen AA, Kelly JP, Bhandari A, Wu MC. Pharmacologic prophylaxis and risk factors for intraoperative floppy-iris syndrome in phacoemulsification performed by resident physicians. Journal of cataract and refractive surgery. 2010 Jun;36(6):898–905.
Lorente R, et al. Intracameral phenylephrine 1.5% for prophylaxis against intraoperative floppy iris syndrome: Prospective, randomized fellow eye study. Ophthalmology. 2012;119(10):2053–8.
Hargitai J, et al. Comparing the efficacy of mydriatic cocktail-soaked sponge and conventional pupil dilation in patients using tamsulosin - a randomized controlled trial. BMC ophthalmology. 2013 Dec;13:83.
Klysik A, Korzycka D. Sub-Tenon injection of 2% lidocaine prevents intra-operative floppy iris syndrome (IFIS) in male patients taking oral a-adrenergic antagonists. AOS Acta Ophthalmologica. 2014;92(6):535–40.
Silverstein SM, et al. Effect of phenylephrine 1.0%-ketorolac 0.3% injection on tamsulosin-associated intraoperative floppy-iris syndrome. Journal of cataract and refractive surgery. 2018 Sep;44(9):1103–8.
Esen F, Bulut AE, Toker E. Efficacy and safety of low-concentration, bisulphite-containing, intracameral epinephrine and topical atropine treatments for the prevention of intraoperative floppy iris syndrome. Cutaneous and Ocular Toxicology. 2018;37(3):286–90.
Nuzzi R, Arnoffi P, Tridico F. Best Prophylactic Strategy in Groups at Risk of Intraoperative Floppy Iris Syndrome Development: Comparison Between Atropine Instillation and Adrenaline Intracameral Injection. The Open Ophthalmology Journal. 2018;12(1):34–40.
Shams F, Jafari AA, Mansfield D. Cardiovascular hazard of intracameral phenylephrine. Journal of Cataract and Refractive Surgery. 2015;41(9):2021–2.
Myers WG. Safety of intracameral phenylephrine. Journal of Cataract and Refractive Surgery. 2016;42(6):944–5.
Stavert B, McGuinness MB, Harper CA, Guymer RH, Finger RP. Cardiovascular adverse effects of phenylephrine eyedrops: A systematic review and meta-analysis. JAMA Ophthalmology. 2015;133(6):647–52.
Karp CL, Cox TA, Wagoner MD, Ariyasu RG, Jacobs DS. Ophthalmic Technology Assessment Intracameral Anesthesia A Report by the American Academy of Ophthalmology. Vol. 108, Ophthalmology. 2001.
Mohammadpour M, Riazi-Esfahani H. Transient complete visual loss and subsequent cystoid macular edema after intracameral lidocaine injection following uneventful cataract surgery. Journal of Current Ophthalmology. 2018;30(2):174–6.
Ostrin LA, Glasser A. The Effects of Phenylephrine on Pupil Diameter and Accommodation in Rhesus Monkeys. Investigative Ophthalmology and Visual Science. 2004;45(1):215–21.
Gonzalez-Salinas R, Guarnieri A, Navarro MCG, Saenz-deViter M, Guirao Navarro MC, Saenz-de-Viteri M. Patient considerations in cataract surgery - the role of combined therapy using phenylephrine and ketorolac. Patient Preference and Aherence. 2016;10:1795–801.
Yu A, Guo H, Wang Q, Bao F, Huang J. Pupil Dilation with Intracameral Epinephrine Hydrochloride during Phacoemulsification and Intraocular Lens Implantation. 2016;2016.
Armarnik S, Mimouni M, Rosen E, Assia EI, Segev F. Modified corneal incisions in intraoperative floppy iris syndrome (IFIS)-prone patients. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2016;254(1):123–7.
Bucci FA, Michalek B, Fluet AT. Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine cataract surgery. Clinical Ophthalmology. 2017;11:1039–43.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2022 Brigitta Marcia Budihardja, Ade Ajeng Cempakadewi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.